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INTRODUCTION
Allergy is currently the leading chronic disease in Europe affecting more than 20% of population. In the close future its prevalence is even predicted to increase of 40%. Around 17 million of European population suffer from food allergies and 3.5 million among patients are under the age of 25. The geographic variability of major allergens is reported to reflect a potential interaction of genetic factors, age, cultural and dietary habits together with the time of first exposure to allergenic products ( . Current medicine does not provide any proactive treatment of food allergy to patients with classical IgE-mediated allergy and they are often prescribed only with symptom controlling drugs. The only way to restrain allergic reactions is to avoid the foods containing dangerous allergen substances (Eigenmann, 2001). The practical implementation of the approach means limitations and adaptations of the diet and lifestyle which is manifested in cautious and prudent purchase and consumption of foodstuffs. Patients with food allergy are limited in public catering since they are not given sufficient information about the meal. The realization of such restrictions is aggravated by the fact that the legislation in many countries does not require products to be labelled with their composition and all allergenic substances. This leads to situations where consumers randomly pick precarious food products which results in allergic reaction with potentially fatal consequences (Burks et al., 2001; Schäppi et al., 2001) . Labeling is an issue of relevance to food allergic patients of fresh, processed and pre-packed foods, as accidental ingestion of food allergens due to labelling amboguities is a modifiable risk factor (Fiocchi et al., 2016) . In the view of the raise in food variety and the increased prevalence of food allergy, avoiding specific foods and allergen ingredients represent a serious interference in comfort and personal life (Fiocchi et al., 2011; Nwaru et al., 2014) . Formation and regulation of conditions for effective labeling of food allergens is an essential issue not only for patients themselves but also for their familiesin Europe it counts about 17 million people. The disproportionality of knowledge and practice is still creating the indisputable need to make the issue a priority task ( Figure 1 ). This study therefore aims to analyze the actual knowledge of cross-reactive food allergens and to emphasize the inconsistency of labeling and also in reaction of practice to scientific findings on the examples of apple allergen Mal d 1 and peach allergen Pru p 3.
Figure 1
Integrated approach to food allergies in research aimed at practical application of acquired knowledge (Žiarovská, Zeleňáková, 2017) Allergies are currently one of the most common chronic diseases which affect millions of people worldwide. The presence of allergens in food products have to be labelled, however, only in case of several classes of allergen source. Actual knowledge points out to the fact, that patients are sensitized by many allergens and often suffer from various cross-allergies. This stresses the existing disproportionality between known data and practice. The study therefore aims to analyze the current state of accessibility to information and disunity in labeling and also in response of practice to scientific findings. Further, based on the examples of apples and peaches, the cross-reactivity of food allergens is discussed for the base of the possible wider labelling in the way that practice will reflect the scientific knowledge more actual.
ACTUAL PRACTICE IN FOOD ALLERGENS LABELING AND RECOMMENDED DISCLOSURE
With the growth of world food production, development of new technological processes as well as more efficient transport systems we have to deal in particular with effective labeling of allergen substances. Allergen labeling laws regulate the way allergens are included on a prepackaged food's label. Besides the EU, allergens are obligatorily marked on food products in Argentina, Australia, Brazil, Canada, China and Hong Kong, Japan, Kuwait, Malaysia, Mexico, New Zealand, Singapore, South Africa, South Korea and the USA (Gendel, 2012; Revák and Golian, 2012; Allen et al., 2014). In the EU the legislative demands labeling of 14 groups, 8 of which are of plant origin (European Commission: Food labeling -EU rules):
 Group 1 -cereals containing gluten (i.e., wheat, rye, barley, oats, kamut or their hybrid varieties) and products thereof 
Group 5 -peanuts and products thereof  Group 6 -soya beans and products thereof  Group 8 -nuts (such as almonds, hazelnuts, walnuts, cashew nuts, pecans nuts, peanuts, pistachios, macadam nuts and Queensland nuts) and products thereof except for nuts which are used for the production of spirits  Group 9 -celery and products thereof  Group 10 -mustard and products thereof  Group 11 -sesame seeds and products thereof  Group 13 -lupin and products thereof When comparing Europe mandatory labeling to other countries, following differencies exist. Tatrazin is required to be labeled in Argentina and Brazil. In Japan, standartly are labeled eggs, milk, wheat, buckwheat, peanuts, shrimps and crabs. Recommended disclosure is for apple, peach, yam, banana, orange, kiwifruit, walnut, abalone, squid, salmon roe, beef, salmon, mackerel, chicken, pork, soybean, Matsuke mushroom and gelatin and a species specification is required for crustaceae. In South Korea, labeling of eggs, milk, wheat, buckwheat, peanuts, soybeans, wheat, mackerel, prawn/shrimp, crab, pork, peaches and tomatoes. Nevertheless, there is a still growing requirement to mark other allergen plant sources, since the list of allergens with prominent evidence of clinical allergy cases is much wider that the required 8 groups of plant food allergens (Table 1) . Cross-reactivity in allergic reactions occurs when the proteins in one substance are similar to the proteins in another. In case of numerous allergens, consumers are exhibited to health-threatening situations even despite easily manageable accessibility of information to increase patients' awareness. Nowadays, allergy to apple protein Mal d 1 is rapidly growing among European population, which is associated with wide distribution of birch pollen. About 11.5% of children aged 0-6 years and 6.6% of adults are allergic to apples (Kiewning and Schmitz-Eiberger, 2014). Food allergies are often cases of secondary allergy caused by a cross-reaction between pollen allergens and their homologs. Here, a patient is sensitised by an aeroallergen from pollen which is later followed by immune response to structurally similar allergens present in different foods (Worm et al.,  2015) . Symptoms and the allergic reaction are usually manifested as oral allergic syndrome (OAS) (Worm et al., 2015) . An example of secondary food allergy is a group of Bet v 1 protein, the main birch pollen allergen and its homologs. Bet v 1 homologs can be found in a wide range of fruits and vegetables with varying degrees of clinical significance (Table  2) . Around 75 % people with birch pollen allergy have OAS after eating food containing its cross-allergens. Botton et al., 2009) . For that reason the allergenicity of an apple strongly depends also on growing and storage conditions (Kiewing et al., 2014) . Patients with testified allergy to apples (by skin prick test, SPT) are in general recommended to avoid consuming apples. However, they lack the information whether they can not eat apples only in fresh form (the case of allergy to unstable protein Mal d 1) or also should avoid heat-processed apples (in case of allergy to thermostable Mal d 2 apple allergen) (Smole et al., 2008) . The disproportionality between compulsory labelled allergens and their crossreactive substances is in practice handled at the level of patients' awareness of the fact. However, the only existing treatmentavoiding consumption of foodstuff containg the allergen, is complicated by several aspects, particularly in the case of panallergens: -obligatory labeling of food allergens involves only a small fraction of them; -data on cross-allergens are not centralized, therefore patients are usually informed only from a flyer or a brochure (Figure 2) ; -counterfeited foodstuffs import allergens which are for patients impossible to trace; -information on cross-allergens from new foods meets patients with a considerable delay.
Figure 2
Example of an availability of information about cross-reacting foods to Bet v 1 sensitized patients (www.allergicliving.com)
The illustrated biological and immunological relation in the example of apple allergen Mal d 1 emphasize the need to reassess the extent and details of patients' awareness. Another example of clinically relevant cross-reacted food is peach and its thermostable allergen -the lipid transfer protein Prup 3. Pru p 3 is an allergen that is the cause of the cross-reaction in the case of patients with mugwort pollen allergy (Lombardero et al., 2004, Gao et al., 2013) . Moreover, the thermostability of Pru 3 causes allergic reactions during the year regardless the peaches harvesting season. In the area of Europen union, fresh peaches are available from April to October, while mugwort pollen is in the air from late June to October. However, hypersensitivity in the wormwood-peach reaction is conditioned in the direction of primary sensitization. For patients with primary allergy to peaches, the reaction to the mugwort pollen allergen is often without of clinical symptoms. For patients with primary wormwood allergy, however, the allergic response to peach allergens is highly probable ( Similarly, cross-reactivity of mugwort and peach is also known in northern China, where patients are also sensitized primarily by wormwood pollen (Gao et  al., 2013) . The predicted geographic expansion of this cross-reaction is based on the predominance of mugwort pollen in the relevant regions. The most recent study, however, is currently describing Pru 3 as a marker allergen for the sensitization of patients to lipid transfer proteins in the environment of Central Europe (Mothes-Luksch et al., 2017) . It is not easy to estimate of prevalence of peach allergy due to differences in study populations, dietary habits or geographical areas (northern or southern Europe) or differences in diagnostic procedures (Bessler aet al., 2000) . Currently reported biological and immunological context of the example of Pru p 3 allergen of peaches point to the need to review the scope and details of mandatory informations about the allergens for the consumer. However, these are united in the EU only for selected groups, and we have found only one web page to find out that, besides the benefits of eating peaches, they also show their allergenicity (Figure 3) .
Figure 3
Information about the allergenic potential of peaches in the web page www.organicfacts.net
INTEGRATION OF THE ALLERGENS MANAGEMENT BY ALLEGOMICS AND IN SILICO GENERATED DATA
A very new approach in the complex management of the allergies is based not only on the cross-reactions, but on combining the existing knowledge with the allergomic one. The definition of allergen itself is dependent on the point of view, if it is immunological, clinical, proteomic or genomic one. When consider the immunological definition, allergen is an IgE reactive antigen in an allergenic patient, but its clinical manifestation has many other circumstances and is based on many factors. The evaluation of allergenic sources is connected to the extention of the diversity of allergens where the all proteins of an allergenic source are analysed as a background net for the allergens itselves and personalized in the relationships of major and minor allergens. Another important evaluation approach is extention of the diversity of IgE response. Here, the IgE specific characteristics in the reaction against allergenic source is asked if is correlate with clinical and sensitization data. All this provide a complementary methods to describe and characterize allergen diversity as well as antibody response diversity (Poncet et al., 2010) .
Another new approach, such as microarray generated data, are a powerful methods, that personalized and find the differences in the specific sensitization profiles of individual allergic patients in the studies (Shahali et al., 2014) . Using of microarray for in vitro diagnosis purposes provide results of IgE binding on more than 100 native and recombinant allergens that are relevant group markers of allergenic sources (Mari et al., 2010) . A many of different allergen reactivities are explored using this approach and are based on physio-pathological models of well characterized and known molecular allergens. The inability of the microarray strategy is to evaluate reactivity to allergens that has not been previously reported. Here, the generating of DNA, cDNA and RNA data is another useful step that can provide a new molecular markers for the proteomically up to now non-defined allergens based on its basic nucleotide sequence homology (Houben at el., 2019; Žiarovská and Zeleňáková, 2019). Combining the basic proteomic, immunological and genomic methods together in the research, an effective workflow (Figure 4) is currenly available for the rapid screening of allergens in the allergen sources and in the future, it will be applicable as a basic data generated approach in the practical and personalized treatment of allergic patients.
Figure 4
Allergens analysis workflow based on allergomics and in silico generated data
CONCLUSION
Based on the current findings the class of plant food sources causing allergies is far wider than the group of plant species which are obligatory required to be designated on food products. In several countries different plant allergens are optionally labelled. Sensitization of patients by pollen allergens is, however, influenced by availability of foods during most of the year and wide distribution of pollen. Therefore, reassessment of existing list of allergens needs to react more promptly.
